Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
6,781 total articles
Pharvaris announced presentation of clinical data supporting the safety of combined use of deucrictibant immediate-release capsules and extended-release tablets for prophylactic and on-demand treatment of bradykinin-mediated angioedema, including hereditary angioedema (HAE). The data suggest adequate safety margins and potential efficacy for this c…
B2Gold Corp. announced the sale of its 70% interest in the Fingold Ventures Ltd. joint venture to Agnico Eagle Mines Limited for US$325 million in cash. Alongside this transaction, the companies have agreed to collaborate on gold mining operations in Nunavut, Canada, aiming to share expertise and improve operational efficiencies in arctic environme…
Silo Pharma highlights its lead program, SPC-15, an intranasal serotonin 4 receptor agonist targeting prophylactic treatment of PTSD, coinciding with President Trump's executive order accelerating psychedelic therapy research. SPC-15 benefits from rapid nose-to-brain delivery and a streamlined regulatory pathway, positioning the company to leverage…
Prelude Therapeutics, a clinical-stage precision oncology company, announced the pricing of an underwritten offering of approximately 18 million shares of common stock and pre-funded warrants to raise gross proceeds of about $90 million. The offering, led by RA Capital Management and participated by other healthcare-focused investors, is expected t…
KANZHUN LIMITED (BOSS Zhipin), a company listed on Nasdaq and Hong Kong stock exchanges, announced April 17th repurchases of 349,698 shares using RMB17.0 million. Year-to-date 2026, the company has invested over RMB913 million in repurchasing shares, reiterating its dedication to enhancing shareholder value.
OwlTing Group, a Nasdaq-listed global fintech company, announced a 12-month extension of lock-up agreements covering over 99% of subject shares, supported by SBI Holdings and legacy shareholders. This move aims to enhance market stability and reflects strong long-term shareholder alignment with OwlTing's strategic focus on expanding its compliant g…
Greenwich LifeSciences announced preliminary Phase III FLAMINGO-01 trial data showing statistically significant increased immune response (delayed-type hypersensitivity reactions) in non-HLA-A*02 breast cancer patients treated with GLSI-100, an immunotherapy targeting HER2-expressing cancers. Early analysis suggests a 70-80% reduction in breast can…
Tower Semiconductor announced it will release its Q1 2026 financial results on May 13, 2026, and hold a conference call to discuss the results and provide Q2 guidance. The company is a leading foundry specializing in analog semiconductor solutions, serving multiple high-growth markets with diverse technology platforms and global manufacturing facil…
USA Rare Earth, Inc. (Nasdaq: USAR) announced a definitive agreement to acquire Serra Verde Group, owner of a key rare earth mine and processing facility in Brazil, for approximately $2.8 billion. This acquisition secures the only large-scale producer outside Asia of all four magnetic rare earth elements critical for advanced technologies. Serra Ve…
Howard Hughes Holdings Inc. appointed Marc Grandisson, former CEO of Arch Capital Group Ltd., to its Board of Directors effective May 2026. Grandisson's expertise in specialty insurance and reinsurance comes as Howard Hughes is finalizing its acquisition of Vantage Group Holdings to expand into the insurance sector, marking a strategic pivot for th…
Prelude Therapeutics presented preclinical data demonstrating that PRT13722, a novel, orally bioavailable, and highly selective KAT6A degrader, shows potent efficacy and an improved safety profile in multiple models of hormone receptor positive, HER2-negative breast cancer. The data suggest enhanced tumor regression and potential for combination th…
Oculis Holding AG has announced the completion of the last patient visits in its Phase 3 DIAMOND program evaluating OCS-01, a novel non-invasive topical eye drop treatment for diabetic macular edema (DME). The program includes over 800 patients across two pivotal trials. Topline results are expected in June 2026, with potential NDA submission later…
Niu Technologies, a leading smart urban mobility company, will report its first quarter 2026 financial results on May 18, 2026, before the U.S. market opens. The company will hold an earnings conference call to discuss the financial and business outcomes. NIU designs and sells electric motorcycles, mopeds, bicycles, scooters, and e-bikes through an…
Allied Gaming & Entertainment Inc. announced that its Board of Directors has established a disciplined pricing approach for future equity issuances in M&A transactions, setting a reference floor price of $2.00 per share, reflecting the company's asset base and platform value. This approach aims to protect existing shareholders amid ongoing strategi…
Nanobiotix announced promising preclinical data demonstrating that its Nanoprimer platform, when used prior to lipid nanoparticle-delivered recombinant DNA immunotherapy, increases systemic bioavailability, reduces liver toxicity, and mitigates inflammatory responses in a mouse model. These findings support further development of Nanoprimer as a th…
Barclays PLC has submitted a TR-1 notification regarding its holdings in Diversified Energy Company, indicating that its total voting rights have fallen below the notifiable threshold. The notification details changes in voting rights ownership and confirms that no major changes surpassing disclosure requirements have occurred.
Kaspi.kz, a leading fintech and super app operator in Kazakhstan and Türkiye, announced a strategic investment by Tencent, Kaspi.kz's Co-Founder and CEO Mikheil Lomtadze, senior management, and US institutional investors acquiring 6 million ADSs from existing shareholders, strengthening the company's capital base as it expands its market leadership…
B2Gold Corp. announced an update on a fire incident at the crushing circuit of its Goose Mine. The fire caused localized damage, with no injuries reported. The company has deployed mobile crushers and plans additional temporary crushing capacity to maintain ore processing. Repairs are expected to conclude by Q3 2026, with the crushing circuit's cap…
Fiserv, Inc. will release its first quarter 2026 earnings results on May 5 before market open, followed by a webcast presentation. Furthermore, the company will hold an Investor Day on May 14 to detail its business strategy and medium-term outlook. Both events will be accessible via live webcast on the company's investor relations website.
Ascendis Pharma A/S has begun trading its ordinary shares on the Nasdaq Global Select Market under ticker ASND, replacing its previous American Depositary Shares (ADSs) listing. This follows a mandatory exchange of all outstanding ADSs for ordinary shares, completed on April 20, 2026.
Commerce's BigCommerce platform has powered Mountain Warehouse's launch of a new composable ecommerce store, replacing their decade-old system. This upgrade allows Mountain Warehouse to scale more efficiently, accelerate innovation, and improve global ecommerce operations, leveraging a flexible, modern tech stack with enhanced security and integrat…
Ardelyx, Inc., a Nasdaq-listed biopharmaceutical firm, announces the appointment of Felecia W. Ettenberg as Chief Legal Officer. Ms. Ettenberg brings over 25 years of legal expertise in the biopharmaceutical industry, most recently from Bristol Myers Squibb. She will lead Ardelyx's legal, compliance, regulatory, and government affairs functions, po…
Astec Industries, a Nasdaq-listed manufacturer specializing in equipment for road building and aggregate processing, announced the appointment of Chad Hartley as Group President of Infrastructure Solutions. Hartley brings extensive leadership experience from Regal Rexnord and Emerson Electric, and is expected to drive operational improvements and c…
Fulcrum Therapeutics, a clinical-stage biopharmaceutical company focused on rare hematological disorders, will release its Q1 2026 financial results on April 27, 2026, prior to market open. Management will hold a conference call and webcast at 8:00 a.m. ET to discuss the results and corporate updates, including progress on their lead program, pocir…
Amneal Pharmaceuticals announced encouraging interim data from its ongoing Phase 4 ELEVATE-PD study evaluating CREXONT®, an extended-release carbidopa/levodopa formulation for Parkinson's disease. Among 111 patients switching from existing therapies such as IR CD/LD and RYTARY®, CREXONT significantly increased daily 'Good On' time by approximately …
